14159, L.P., Director, 10% Owner at SEATTLE GENETICS INC /WA (SGEN), bought 1,278,403 shares at $33.06 ($42.2M) on 2014-12-08, disclosed to the SEC on 2014-12-10.
Open-market purchase of $42.2M SGEN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.56 | 216,284 | $7.0M | 16.7% |
| 2 | $33.00 | 38,614 | $1.3M | 3.0% |
| 3 | $33.06 | 24,890 | $823K | 1.9% |
| 4 | $33.31 | 185,528 | $6.2M | 14.6% |
| 5 | $0.00 | 30,507 | $0 | 0.0% |
| 6 | $33.28 | 42,500 |
| $1.4M |
| 3.4% |
| 7 | $33.90 | 5,500 | $186K | 0.4% |
| 8 | $34.64 | 80,430 | $2.8M | 6.6% |
| 9 | $34.27 | 354,000 | $12.1M | 28.7% |
| 10 | $34.33 | 185,378 | $6.4M | 15.1% |
| 11 | $34.53 | 14,772 | $510K | 1.2% |
| 12 | $34.95 | 100,000 | $3.5M | 8.3% |
| Total | $33.02 avg | 1,278,403 | $42.2M | 100% |
| Filing → |
| GHDX | SELL | 2019-01-14 | $2.8M | — | Filing → |
| ACAD | BUY | 2018-12-04 | $200.0M | — | Filing → |
| GHDX | SELL | 2018-12-03 | $15.9M | — | Filing → |